Efficacy of minimally invasive surfactant therapy in moderate and late preterm infants: A multicentre randomized control trial
- 27 April 2017
- journal article
- Published by Oxford University Press (OUP) in Paediatrics & Child Health
- Vol. 22 (3) , 120-124
Abstract
Minimally invasive surfactant therapy (MIST) is a new strategy to avoid mechanical ventilation (MV) in respiratory distress syndrome. The primary aim of this study was to test MIST as a means of avoiding MV exposure and pneumothorax occurrence in moderate and late preterm infants (32 to 36 weeks’ gestational age). This was a randomized controlled trial including three Canadian centres. Patients were randomized to standard management or to the intervention if they required nasal continuous positive airway pressure of 6 cm H2O and 35% FiO2 in the first 24 hours of life. Patients from the intervention group received MIST immediately after inclusion. The primary outcome was either need for MV or development of a pneumothorax requiring a chest tube. To ensure that clinicians were not biased toward delaying intubation in the intervention group, clinical failure criteria were also used as a primary outcome. The primary outcome was analyzed using bivariate and multivariate logistic regressions. Among 45 randomized patients, 24 were assigned to MIST and 21 to standard management. Eight infants (33%) from the intervention group met the primary outcome criteria versus 19 (90%) in the control group (absolute risk reduction 0.57, 95% confidence interval 0.54 to 0.60). One patient in each group reached the primary outcome because of pneumothorax occurrence. The other patients were exposed to MV. None of the patients reached the clinical failure criteria. MIST for respiratory distress syndrome management in moderate and late preterm infants was associated with a significant reduction of MV exposure and pneumothorax occurrence.Keywords
This publication has 28 references indexed in Scilit:
- Impact of Late Preterm and Early Term Infants on Canadian Neonatal Intensive Care UnitsAmerican Journal of Perinatology, 2013
- RDS – CPAP or surfactant or bothActa Paediatrica, 2012
- Avoidance of mechanical ventilation by surfactant treatment of spontaneously breathing preterm infants (AMV): an open-label, randomised, controlled trialThe Lancet, 2011
- Randomized Trial Comparing 3 Approaches to the Initial Respiratory Management of Preterm NeonatesPediatrics, 2011
- A systematic review of severe morbidity in infants born late pretermAmerican Journal of Obstetrics and Gynecology, 2011
- Preliminary evaluation of a new technique of minimally invasive surfactant therapyArchives of Disease in Childhood - Fetal and Neonatal Edition, 2010
- Respiratory Morbidity and Lung Function in Preterm Infants of 32 to 36 Weeks' Gestational AgePediatrics, 2010
- Early CPAP versus Surfactant in Extremely Preterm InfantsNew England Journal of Medicine, 2010
- Nasal CPAP or Intubation at Birth for Very Preterm InfantsNew England Journal of Medicine, 2008
- Early administration of surfactant in spontaneous breathing with nCPAP: feasibility and outcome in extremely premature infants (postmenstrual age ≤27 weeks)Pediatric Anesthesia, 2006